More Neurotech International Ltd. news
Neurotech International Ltd.ASX: NTI

Mente Autism - FDA Clearance Application

Oct 1, 2018 at 10:45 PM EDT · Issued by Neurotech International Ltd.

Filed with ASX · Oct 1, 2018 at 10:45 PM EDT

On 6ix: 6ix.com/news/mente-autism-fda-clearance-application

Neurotech International Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Neurotech International Ltd. on 6ix

Story so far

  • First Shipments of Mente AutismAug 10, 2018
  • Mente Autism Approval From ItalcertJun 4, 2018
  • Mente Autism UpdateJun 5, 2017

Earlier from Neurotech International

  • First Shipments of Mente AutismAug 9, 2018
  • Quarterly report and Appendix 4CJul 31, 2018
  • US Clinical Trial Results PublishedJul 8, 2018
  • Mente Autism Approval From ItalcertJun 4, 2018
  • Appendix 4D and 31 December 2017 Half Year Financial ReportFeb 28, 2018

Later from Neurotech International

  • Shipment of Mente Autism devicesOct 3, 2018
  • Quarterly reportOct 18, 2018
  • New AppointmentsOct 22, 2018
  • Appointment of Peter Griffiths as CEONov 25, 2018
  • Investor PresentationJan 28, 2019
All Neurotech International news releases↗

Follow Neurotech International into a list and get an email when it puts out news.

Follow Neurotech International
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer